Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Hepatol. Aug 27, 2022; 14(8): 1576-1583
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1576
Table 1 Baseline characteristics
Total number of patients
131
Age, yr47.75 ± 1.08
Gender, n (%)
Male90 (69)
Female41 (31)
Aboriginal or Torres Strait Islander, n (%)17 (13)
Presence of cirrhosis, n (%)
Cirrhosis9 (6.9)
No clinical evidence of cirrhosis122 (93.1)
New diagnosis of HCV, n (%)
Yes10 (7.6)
No121 (92.4)
Unit of admission, n (%)
Medical41 (31)
Surgical37 (28)
Mental health38 (29)
Emergency department15 (11)
Referral for DAA treatment, n (%)
Yes32 (24.4)
No99 (75.6)
Outcome after referral, n (%)
Attendance at specialist clinic14 (10.6)
Initiation of DAA treatment13 (9.9)
Achievement of SVR128 (6.1)